Bimal Shah

Director/Board Member at ANEBULO PHARMACEUTICALS, INC.

48 year

Health Technology

Consumer Services

Profile

Bimal R.
Shah currently works at Anebulo Pharmaceuticals, Inc., as Independent Director from 2023 and Allos Therapeutics, Inc., as Chief Financial Officer & Treasurer from 2012.
Mr. Shah also formerly worked at Spectrum Pharmaceuticals, Inc., as Vice President-Corporate & Business Development from 2013 to 2021.
Mr. Shah received his undergraduate degree, graduate degree, and Masters Business Admin degree from Stanford University.

Bimal Shah active positions

Companies	Position	Start
ANEBULO PHARMACEUTICALS, INC.	Director/Board Member	2023-10-04
Allos Therapeutics, Inc. Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.	Director of Finance/CFO	2012-09-04

All active positions of Bimal Shah

Former positions of Bimal Shah

Companies	Position	End
SPECTRUM PHARMACEUTICALS, INC.	Corporate Officer/Principal	2020-12-31

See the detail of Bimal Shah's experience

Training of Bimal Shah

Stanford University

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bimal Shah's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
SPECTRUM PHARMACEUTICALS, INC.	Health Technology
ANEBULO PHARMACEUTICALS, INC.	Health Technology

Private companies	1
Allos Therapeutics, Inc. Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.	Health Technology